| 医院获得性肺炎4种治疗方案的成本-效果分析 |
| |
| 引用本文： | 张晓冬,陈勇,唐文渊.医院获得性肺炎4种治疗方案的成本-效果分析[J].中国药房,2002,13(6):340-341. |
| |
| 作者姓名： | 张晓冬 陈勇 唐文渊 |
| |
| 作者单位： | 1. 重庆医科大学附属第一医院神经外科,重庆市,400016
2. 重庆市大足县人民医院,重庆市,402360 |
| |
| 摘 要： | 目的 :评价4种治疗方案的药物经济学效果。方法 :运用成本 -效果分析法对4种治疗方案进行分析。结果 :头孢曲松、亚胺培南的成本 -效果比基本相当 ,较头孢呋辛与庆大霉素联合用药的成本 -效果比低 ;头孢曲松成本较低 ,而亚胺培南治愈率及总有效率最高 ;哌拉西林与丁胺卡那联合用药的成本最低 ,但治愈率和有效率亦低。结论 :药物经济学在优化治疗方案、指导合理用药、提高经济效益方面具有重要作用
|
| 关 键 词： | 医院获得性肺炎 药物经济学 成本-效果分析 |
| 文章编号： | 1001-0408(2002)06-0340-02 |
| 修稿时间： | 2002年1月11日 |
The Cost- effectiveness Analysis of Four Therapeutic Schemes for Nosocomial Pulmonary Infections |
| |
| ZHANG Xiaodong,TANG Wenyuan.The Cost- effectiveness Analysis of Four Therapeutic Schemes for Nosocomial Pulmonary Infections[J].China Pharmacy,2002,13(6):340-341. |
| |
| Authors: | ZHANG Xiaodong TANG Wenyuan |
| |
| Abstract: | OBJECTIVE:To evaluate the pharmacoeconomic effectiveness of four therapeutic schemes METHODS:By using cost-effectiveness analysis,four therapeutic schemes for nosocomial pulmonary infections were analysed RESULTS:The cost-effectiveness ratio of ceftriaxone and imipenem was lower than that of cefuroxime and gentamycin The cost of ceftriaxone was low and imipenem had the highest curative rate and total effective rate The cost-effectiveness ratio of piperacillin and amikacin was the lowest,but the curative rate and effective rate of them were the lowest too CONCLUSION:Pharmacoeconomics plays an important role in optimizing therapeutic scheme,guiding rational use of drug and rising the economic benefit |
| |
| Keywords: | nosocomial pulmonary infection pharmacoeconomics cost-effective analysis |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
